The FDA Sentinel Initiative — An Evolving National Resource

Richard Platt, Jeffrey S. Brown, Melissa A. Robb, Mark McClellan, Robert Ball, Michael Nguyen, Rachel E. Sherman

New England Journal of Medicine · 2018 · 206 citations · 2 references

Concepts

Abstract

A decade after the launch of the FDA Sentinel Initiative, it has matured from a pilot program designed to assess potential drug-safety signals in insurance claims into a core component of the agency’s evolving safety surveillance system.

References

2